How to Overcome Addiction to Substances or Behaviors | Dr. Keith Humphreys

Episode Summary

Executive Summary: Dr. Keith Humphreys frames addiction as progressive narrowing of pleasure and control, shaped by genetics, brain plasticity, age of exposure, and industry incentives. He compares alcohol, cannabis, stimulants, nicotine, gambling, psychedelics, SSRIs, and GLP-1s, emphasizing that effective treatment combines motivation, social support, accountability, and often 12-step or evidence-based care. He also argues for stronger regulation of addictive products and policies that reduce harm without moralizing.

Main Topics: Defining addiction and why it persists (Priority: 5/5): Addiction is not mere frequent use; it is continued use despite harm, often with progressive loss of other rewards, relationships, and functioning. Humphreys emphasizes maladaptive learning and brain changes rather than moral failure. Genetics, early exposure, and substance-specific risk (Priority: 5/5): Genetic risk is meaningful but not destiny. Family history, sex differences, and age of first use strongly affect vulnerability, with early initiation during brain plasticity raising risk across substances and behaviors. Alcohol: health risk, marketing, and social pressure (Priority: 5/5): Humphreys argues alcohol has no net health benefit strong enough to outweigh risks, especially cancer. He critiques industry marketing, the myth of red-wine benefits, and social norms that pressure people to drink. Cannabis: higher potency, daily use, and developmental harms (Priority: 5/5): Modern cannabis is far stronger and used more frequently than decades ago. He warns about psychosis risk in vulnerable youth, cognitive and motivational impairment, and the difference between decriminalization and commercialization. Treatment models: 12-step, contingency management, TMS, and psychedelics (Priority: 4/5): He praises AA/12-step for accessibility and evidence, supports contingency management for stimulant use, sees promise in RTMS/TMS, and views psychedelics and ketamine as promising but needing rigorous trials and safety oversight. Industry-driven addiction and public policy (Priority: 5/5): Alcohol, gambling, cannabis, nicotine, and digital platforms are designed to maximize engagement and profit, often by exploiting addiction. Humphreys calls for taxes, ad restrictions, and tighter regulation. Social media, phones, and modern behavioral addiction (Priority: 4/5): He extends addiction logic to phones, social media, porn, and gaming, noting that cues, novelty, and constant access can hijack attention. He recommends environmental controls and social norms, not just self-control.

Key Arguments: Addiction is best understood as persistent use of something harmful, not just doing something a lot. The strongest risk factors are family history, early exposure, and brain plasticity during adolescence. Alcohol’s supposed cardiovascular benefit is outweighed by cancer and other harms; zero is safest. Cannabis today is much more potent than in the past, so historical comparisons are misleading. Legalization increases corporate promotion and consumption; decriminalization is not the same as commercialization. AA/12-step programs work especially well for alcohol because they are immediate, free, accessible, and socially reinforcing. Contingency management is the clearest effective behavioral treatment for stimulant addiction. RTMS/TMS is promising for depression and may extend to some addictions, with fewer downsides than ketamine. Psychedelics may help some patients in supervised settings, but microdosing lacks evidence and trials must be rigorous. GLP-1 drugs may reduce cravings and could become useful for alcohol and other addictions, but research is early. Social media and gambling are engineered to exploit reward circuitry through novelty, cues, and variable reinforcement. Treatment should focus on motivation, concrete carrots/sticks, social support, and reducing exposure to cues. People can recover through many pathways; not all need formal treatment, but some need pressure or mandated care.

Data Points: Genetic contribution to substance risk: ~0.3 to 0.5 - Humphreys says shared heritability for addiction risk is often in this range across substances. Alcohol share by heavy users: ~10% of the population drinks about half the alcohol - Used to explain why alcohol companies target heavy drinkers. Women's drinking increase: Substantial increase in the late 1990s and early 2000s - Attributed to alcohol-industry marketing campaigns aimed at women. Alcohol use guideline discussed: About 2 drinks per week - Presented as a very low-risk upper limit for non-alcoholic adults, though not risk-free. Alcohol-related deaths in the U.S.: About 150,000 per year - Used to argue alcohol is treated too casually relative to its mortality burden. U.S. alcohol use prevalence: At an all-time low in some statistics - Humphreys notes drinking appears to be declining, especially among younger cohorts. Cannabis THC content in the 1980s/1990s: ~3% to 5% - Historical average potency for older cannabis products. Cannabis THC content in legal markets today: ~20% average - He describes modern cannabis as dramatically stronger than older products. Daily or near-daily cannabis use: ~42% of users - Used to show how contemporary consumption patterns differ from the past. Brain exposure increase from older vs newer cannabis use: ~65x higher - Humphreys combines potency and frequency changes to estimate much higher exposure. Psychosis timing risk window: Teen years and late single-digit years - He says the highest vulnerability is during early brain development. Caffeine use globally: ~90% of adults use caffeine - To distinguish common, functional stimulants from more dangerous ones. AA effect on abstinence outcomes: ~50% higher rates - From a Cochrane review, AA/12-step facilitation outperformed comparison therapies for stopping drinking. U.S. recovery population: ~24 million Americans - He cites survey estimates to normalize recovery as common and achievable. Male-to-female ratio in opioid addiction: About 4:1 - Humphreys says men are overrepresented in major addictions. Alcohol gender ratio: About 60:40 male to female - He notes women have increased drinking but men still dominate overall. Post-psychedelic depression relief/remission: ~60% to 70% - Describes outcomes from supervised psilocybin-like interventions for treatment-resistant depression. Medicaid policy change impact: About $1 trillion cut over coming years - He warns this could reduce access to addiction treatment for low-income people.

Pivotal Quotes: "The other thing that's really important is that, like any other, anytime you're making a behavior change, hang out with other people who are trying to make the same change." — Dr. Keith Humphreys: On why social support and accountability are central to recovery. "You can't get addicted to something that you've never done or taken." — Dr. Keith Humphreys: Advice to young people about maximal control over addiction risk. "The more addiction there is, the better off they do financially." — Dr. Keith Humphreys: On the business incentives driving alcohol, gambling, cannabis, nicotine, and digital products.

Implications: Listeners are urged to treat addiction as a modifiable brain-and-behavior problem shaped by exposure and incentives, not weakness. The episode supports earlier intervention, tighter regulation of addictive products, and practical recovery tools that reduce cues and build community.